Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „liposomal“
Suchtreffer
Begriffe & Kennungen
Onivyde pegylated liposomal (previously Onivyde) · 4.8 · ONIVYDE pegylated liposomal in combination with oxaliplatin, 5-fluorouracil and leucovorin: In NAPOLI-3, Infus
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · ONIVYDE pegylated liposomal in combination with oxaliplatin, 5-fluorouracil and leucovorin: In NAPOLI-3, renal
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · ONIVYDE pegylated liposomal in combination with oxaliplatin, 5-fluorouracil and leucovorin: In NAPOLI-3, safet
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Other special populations
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Overall, no major clinical differences in safety were reported between patients ≥ 65 years and patients < 65 y
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Patients with UGT1A1 allele
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Patients with hepatic impairment
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Summary of the safety profile
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Table 4: Adverse reactions reported in patients treated with ONIVYDE pegylated liposomal
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · The adverse reactions described in this section are derived from studies data and post-marketing experience of
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Thrombocytopenia
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · Underweight patients (body mass index < 18.5 kg/m2)
Eintrag öffnenVyxeos liposomal (previously Vyxeos)
Eintrag öffnenVyxeos liposomal (previously Vyxeos) · 4.1 Therapeutic indications · 1
Eintrag öffnenVyxeos liposomal (previously Vyxeos) · 4.3 Contraindications · 1
Eintrag öffnenVyxeos liposomal (previously Vyxeos) · 4.3 · History of serious hypersensitivity to the active substances or to any of the excipients listed in section 6.1
Eintrag öffnenVyxeos liposomal (previously Vyxeos) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnen